Ads
related to: breast cancer drug- Information For HCPs
Helpful Resources Available for
ER+/HER2- mBC Treatment.
- Savings & Support
Assistance Program For Patients
with ER+/HER2- mBC Seeking Support.
- ER+/HER2- mBC Treatment
Learn About An FDA Approved
ER+/HER2- mBC Therapy.
- ER+/HER2- mBC Therapy
See Info On FDA Approved Oral
Therapy For ER+/HER2- mBC.
- Request Information
Get Connected With a Sales
Representative Today.
- Access & Reimbursement
Discover If Your Patients Are
Eligible For Insurance Coverage.
- Information For HCPs
Search results
...Elacestrant (ORSERDU®) in Patients with ER+, HER2- MetastaticBreast Cancer (mBC) at the ASCO 2024...
WJTV Jackson· 6 days agoThe ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms and improve patient outcomes with oral-oral combination options. Updated results from the ELECTRA study ...
AstraZeneca shares target raised by Argus on new drug approvals By Investing.com
Investing.com· 8 hours agoOn Thursday, AstraZeneca PLC (NASDAQ:LON:AZN) shares received an updated price target from a market...
EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001,...
ThePress.net· 7 days agoThis activity includes complete responses and several durable partial responses in established checkpoint inhibitor-resistant tumor types like sarcoma and triple negative breast< ...
Peninsula cancer test maker lands key nod from FDA panel, a step toward a big payday - San Francisco...
The Business Journals· 6 days agoShares of Guardant Health Inc. closed Friday more than 13% higher day-over-day, after the Palo Alto...
Ignoring Colonoscopy Advice; Inflamed Tongue, Then Cancer; Acupuncture for Dry Mouth
MedPage Today· 7 days agoNews, features, and commentary about cancer-related issues
Latest American Cancer Society study places emphasis on cancer disparities among Black women
WREG articles via Yahoo News· 4 days agoMEMPHIS, Tenn. — According to the American Cancer Society, research shows black women have the...
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3
FierceBiotech· 2 days agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
WJET - WFXP Erie· 6 days agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual...
Antibody–peptide inhibitor conjugates: A new path for cancer therapy
Medical Xpress· 1 day agoAn example of essential proteins hijacked by cancer cells are the cathepsins, a family of enzymes that is responsible for breaking down other proteins and remodeling the body's ...
Empower women employees to manage their health with tax-free funds
BenefitsPRO· 2 hours agoTalk of women's health concerns, from periods to pregnancy to menopause, used to be taboo. As...
Ads
related to: breast cancer drug